Literature DB >> 12780350

Regulation of alternative splicing of Gtf2ird1 and its impact on slow muscle promoter activity.

Enoch S E Tay1, Kim L Guven, Nanthakumar Subramaniam, Patsie Polly, Laura L Issa, Peter W Gunning, Edna C Hardeman.   

Abstract

A human MusTRD (muscle TFII-I repeat domain (RD)-containing protein) isoform was originally identified in a yeast one-hybrid screen as a protein that binds the slow fibre-specific enhancer of the muscle gene troponin I slow [O'Mahoney, Guven, Lin, Joya, Robinson, Wade and Hardeman (1998) Mol. Cell. Biol. 18, 6641-6652]. MusTRD shares homology with the general transcription factor TFII-I by the presence of diagnostic I-RDs [Roy (2001) Gene 274, 1-13]. The human gene encoding MusTRD, GTF2IRD1 ( WBSCR11 / GTF3 ), was subsequently located on chromosome 7q11.23, a region deleted in the neurodegenerative disease, Williams-Beuren Syndrome [Osborne, Campbell, Daradich, Scherer, Tsui, Franke, Peoples, Francke, Voit, Kramer et al. (1999) Genomics 57, 279-284; Franke, Peoples and Francke (1999) Cytogenet. Cell. Genet. 86, 296-304; Tassabehji, Carette, Wilmot, Donnai, Read and Metcalfe (1999) Eur. J. Hum. Genet. 7, 737-747]. The haploinsufficiency of MusTRD has been implicated in the myopathic aspect of this disease, which manifests itself in symptoms such as lowered resistance to fatigue, kyphoscoliosis, an abnormal gait and joint contractures [Tassabehji, Carette, Wilmot, Donnai, Read and Metcalfe (1999) Eur. J. Hum. Genet. 7, 737-747]. Here, we report the identification of 11 isoforms of MusTRD in mouse skeletal muscles. These isoforms were isolated from a mouse skeletal muscle cDNA library and reverse transcription-PCR on RNA from various adult and embryonic muscles. The variability in these isoforms arises from alternative splicing of a combination of four cassettes and two mutually exclusive exons, all in the 3' region of the primary transcript of Gtf2ird1, the homologous mouse gene. The expression of some of these isoforms is differentially regulated spatially, suggesting individual regulation of the expression of these isoforms. Co-transfection studies in C2C12 muscle cell cultures reveal that isoforms differentially regulate muscle fibre-type-specific promoters. This indicates that the presence of different domains of MusTRD influences the activity exerted by this molecule on multiple promoters active in skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12780350      PMCID: PMC1223606          DOI: 10.1042/BJ20030189

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

1.  Domain structure of the NRIF3 family of coregulators suggests potential dual roles in transcriptional regulation.

Authors:  D Li; F Wang; H H Samuels
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

2.  Role of denervation in modulating IIb MHC gene expression in response to T(3) plus unloading state.

Authors:  N A di Maso; F Haddad; M Zeng; S A McCue; K M Baldwin
Journal:  J Appl Physiol (1985)       Date:  2000-02

3.  Characterization and gene structure of a novel retinoblastoma-protein-associated protein similar to the transcription regulator TFII-I.

Authors:  X Yan; X Zhao; M Qian; N Guo; X Gong; X Zhu
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

4.  Genomic organization of the genes Gtf2ird1, Gtf2i, and Ncf1 at the mouse chromosome 5 region syntenic to the human chromosome 7q11.23 Williams syndrome critical region.

Authors:  Dashzeveg Bayarsaihan; Judit Dunai; John M Greally; Kazuhiko Kawasaki; Kenta Sumiyama; Badam Enkhmandakh; Nobuyoshi Shimizu; Frank H Ruddle
Journal:  Genomics       Date:  2002-01       Impact factor: 5.736

5.  Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle.

Authors:  D Yaffe; O Saxel
Journal:  Nature       Date:  1977 Dec 22-29       Impact factor: 49.962

6.  The CACC box and myocyte enhancer factor-2 sites within the myosin light chain 2 slow promoter cooperate in regulating nerve-specific transcription in skeletal muscle.

Authors:  K Esser; T Nelson; V Lupa-Kimball; E Blough
Journal:  J Biol Chem       Date:  1999-04-23       Impact factor: 5.157

7.  A transcription factor involved in skeletal muscle gene expression is deleted in patients with Williams syndrome.

Authors:  M Tassabehji; M Carette; C Wilmot; D Donnai; A P Read; K Metcalfe
Journal:  Eur J Hum Genet       Date:  1999 Oct-Nov       Impact factor: 4.246

8.  Identification of GTF2IRD1, a putative transcription factor within the Williams-Beuren syndrome deletion at 7q11.23.

Authors:  Y Franke; R J Peoples; U Francke
Journal:  Cytogenet Cell Genet       Date:  1999

9.  Cytoplasmic activation of human nuclear genes in stable heterocaryons.

Authors:  H M Blau; C P Chiu; C Webster
Journal:  Cell       Date:  1983-04       Impact factor: 41.582

10.  The role of a Williams-Beuren syndrome-associated helix-loop-helix domain-containing transcription factor in activin/nodal signaling.

Authors:  Colleen Ring; Souichi Ogata; Lauren Meek; Jihwan Song; Tatsuru Ohta; Kohei Miyazono; Ken W Y Cho
Journal:  Genes Dev       Date:  2002-04-01       Impact factor: 11.361

View more
  8 in total

1.  The nuclear localization pattern and interaction partners of GTF2IRD1 demonstrate a role in chromatin regulation.

Authors:  Paulina Carmona-Mora; Jocelyn Widagdo; Florence Tomasetig; Cesar P Canales; Yeojoon Cha; Wei Lee; Abdullah Alshawaf; Mirella Dottori; Renee M Whan; Edna C Hardeman; Stephen J Palmer
Journal:  Hum Genet       Date:  2015-08-15       Impact factor: 4.132

Review 2.  Excitation-transcription coupling in skeletal muscle: the molecular pathways of exercise.

Authors:  Kristian Gundersen
Journal:  Biol Rev Camb Philos Soc       Date:  2010-10-06

3.  Negative autoregulation of GTF2IRD1 in Williams-Beuren syndrome via a novel DNA binding mechanism.

Authors:  Stephen J Palmer; Nicole Santucci; Jocelyn Widagdo; Sara J Bontempo; Kylie M Taylor; Enoch S E Tay; Jeff Hook; Frances Lemckert; Peter W Gunning; Edna C Hardeman
Journal:  J Biol Chem       Date:  2009-12-09       Impact factor: 5.157

4.  Evolution of general transcription factors.

Authors:  K V Gunbin; A Ruvinsky
Journal:  J Mol Evol       Date:  2012-12-11       Impact factor: 2.395

5.  Alternative splicing and promoter use in TFII-I genes.

Authors:  Aleksandr V Makeyev; Dashzeveg Bayarsaihan
Journal:  Gene       Date:  2008-12-09       Impact factor: 3.688

6.  Determination and functional analysis of the consensus binding site for TFII-I family member BEN, implicated in Williams-Beuren syndrome.

Authors:  Maria B Lazebnik; Maria Isabel Tussie-Luna; Ananda L Roy
Journal:  J Biol Chem       Date:  2008-03-07       Impact factor: 5.157

7.  SUMOylation of GTF2IRD1 regulates protein partner interactions and ubiquitin-mediated degradation.

Authors:  Jocelyn Widagdo; Kylie M Taylor; Peter W Gunning; Edna C Hardeman; Stephen J Palmer
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

8.  Deletion of the Williams Beuren syndrome critical region unmasks facioscapulohumeral muscular dystrophy.

Authors:  Carmelo Rodolico; Luisa Politano; Simona Portaro; Stefania Murru; Loredana Boccone; Francesco Sera; Luigia Passamano; Teresa Brizzi; Rossella Tupler
Journal:  Eur J Paediatr Neurol       Date:  2020-05-22       Impact factor: 3.140

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.